Here are three takeaways:
1. The article examined the cost-effectiveness of two-level cervical total disc replacement with the Mobi-C Cervical Disc as compared to anterior cervical discectomy and fusion based on five-year outcomes data.
2. The study found that for patients with two-level degenerative disc disease, TDR with Mobi-C seems to be a “highly cost-effective surgical modality compared with ACDF.”
3. Mobi-C is a cobalt chromium alloy and polyethylene mobile-bearing device that is designed as a bone-sparing, cervical intervertebral disc replacement for both one and two-level indications.
“We are excited to have this very important, long-term economic analysis of Mobi-C published, especially in such a prestigious journal as Neurosurgery. The principal finding of this study, that two-level Mobi-C appears to offer improved cost-effectiveness compared to ACDF (based on the 60-month outcomes), represents further evidence to support broader payer coverage for two-level cervical disc replacement and greater surgeon adoption of Mobi-C,” said Christophe Lavigne, president and CEO of LDR.
More articles on devices:
Spine surgery reimbursement: Key thoughts on coverage for new technology
Stryker buys Synergetics’ neuro portfolio on the heels of Sage acquisition: 5 key notes
NuVasive establishes new 52-week low: 4 points
